Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;50(9):7815-7823.
doi: 10.1007/s11033-023-08666-0. Epub 2023 Jul 24.

Biomarkers of liver diseases

Sukhbir Singh Tamber  1 , Palak Bansal  1 , Suraj Sharma  1 , Rai Barinder Singh  1 , Ramica Sharma  2
Affiliations
Review

Biomarkers of liver diseases

Sukhbir Singh Tamber et al. Mol Biol Rep. 2023 Sep.

Abstract

The liver is one of the pivotal organs in the human body and is fundamentally responsible for detoxification and metabolism. Various disorders such as non-alcoholic fatty liver disease, fibrosis, cirrhosis, hepatocellular carcinoma, and hepatitis are associated with improper functions of the liver. Hence, biomarkers are needed to determine the severity. Further, many liver enzymes, including the cascade of aspartate aminotransferase (AST)/serum glutamic oxaloacetic transaminase (SGOT), alanine aminotransferase (ALT)/serum glutamic pyruvic transaminase (SGPT), alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), and total bilirubin (TBIL), are conventional liver biomarkers. They are not, however, unique to the liver; hence, efforts are being made to identify the precise biomarkers for liver illness that can target liver diseases. HMGB1, cytokeratin 18 (K18), glutathione-S-transferase-α (GST-α), glutamate dehydrogenase (GLDH), malate dehydrogenase (MDH), and microRNAs (miRNA) are a few examples of developing biomarkers used to detect many liver diseases. Hence, the review has highlighted various novel biomarkers of the liver so that various pathophysiological pathways and treatments can be made easier.

Keywords: ALT; Biomarkers; Fibrosis; HMGB1; Liver; NAFLD.

PubMed Disclaimer

References

    1. Ozougwu JC (2017) Physiology of the liver. Int J Res Pharm Biosci 4(8):13–24
    1. Ozougwa JC, Eyo JE (2014) Hepatoprotective effects of Allium cepa (onion) extracts against paracetamol-induced liver damage in rats. Afr J Biotechnol 13(26): 2679–2688
    1. Moore KL, Dalley AF, Agur AM (2013) Clinically oriented anatomy. Lippincott Williams & Wilkins
    1. Guyton AC, Hall JE (1986) Textbook of medical physiology. Saunders, Philadelphia
    1. Yang X, Schnackenberg LK, Shi Q, Salminen WF (2014) Hepatic toxicity biomarkers. In: Biomarkers in toxicology, pp 241–259. Academic Press

LinkOut - more resources